Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma
Clinical trial NCT04172805 · COMPLETED
Trial details
- NCT number
- NCT04172805
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-13
- Primary completion
- 2025-10-31
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.